![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A comparison of currently available direct acting antiviral HCV therapy in Canada - On the path to elimination
|
|
|
Reported by Jules Levin
International Liver Congress (EASL), 10-14 April 2019, Vienna, Austria
A. ALIMOHAMMADI1, J. HOLEKSA1, T. MAGEL1, D. TRUONG1, A. THIAM1, R. YUNG1, L. CHU1, B. CONWAY1
1 Vancouver Infectious Diseases Centre, Vancouver, Canada
![0507191](../images/050719/050719-12/0507191.gif)
![0507192](../images/050719/050719-12/0507192.gif)
![0507193](../images/050719/050719-12/0507193.gif)
![0507194](../images/050719/050719-12/0507194.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|